This week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of ...

Johnson & Johnson has signaled that it will attempt to disqualify certain plaintiffs' lawyers and use other aggressive ...

The EV maker is slated to report first-quarter sales data Wednesday morning. Wall Street expects just under 380,000 vehicles. The number reported probably won't be that high.

A federal bankruptcy judge has rejected Johnson & Johnson’s latest attempt to settle lawsuits that allege its talc baby ...

A Johnson & Johnson unit’s latest dismissal from the bankruptcy court system shows how complex voting issues and overly broad ...

Bankruptcy judge rejects the healthcare-products company’s third attempt to resolve mass talc lawsuits through chapter 11.

A 110-year-old lemon that played a key role in espionage history is one of the star attractions of a London exhibition drawn ...

A judge dismissed an attempt to use a bankruptcy court to resolve tens of thousands of claims that the company’s talcum power ...

A federal judge has rejected Johnson & Johnson’s latest attempt to resolve lawsuits its talc products caused cancer, ruling ...

Johnson & Johnson’s plan to settle thousands of talc-related lawsuits through bankruptcy was shot down in court.

Johnson & Johnson faces a setback in its talc cases bankruptcy plan but reaffirms confidence in financial guidance. Read more ...